Drugs: Pressemitteilungen - Kategorie - Seite 65

Drugs

Category / Pharmaceuticals & Biotech / Drugs


Cadus Announces Resignation of Russell Glass as Director

NEW YORK, NY: NEW YORK, NY -- (Marketwire) -- 08/18/11 -- (OTCBB: KDUS) announced today that Russell Glass has decided to resign from the board of directors of Cadus effective immediately in order to focus on his ...

ISTA Pharmaceuticals to Present at Southern California Investor Conference and Stifel Nicolaus Annual Healthcare Conference

IRVINE, CA: IRVINE, CA -- (Marketwire) -- 08/18/11 -- ISTA Pharmaceuticals, Inc. (NASDAQ: ISTA) today announced its executives will present at two conferences in August and September. Both conference presentati ...

Biota Announces Preliminary Full Year Report

MELBOURNE, AUSTRALIA: MELBOURNE, AUSTRALIA -- (Marketwire) -- 08/17/11 -- Biota Holdings Limited (ASX: BTA)BARDA awarded a major contract to Biota for the advanced development of laninamivir in the US. The US$231 millio ...

Labopharm Inc. Enters Into an Agreement to Be Acquired by Paladin Labs Inc.

MONTREAL AND LAVAL, QUEBEC: MONTREAL AND LAVAL, QUEBEC -- (Marketwire) -- 08/17/11 -- Paladin Labs Inc. ("Paladin")(TSX: PLB) and Labopharm Inc. ("Labopharm")(TSX: DDS) announced today that they have entere ...

RXT 110 INC. Announces Adoption of an Employee Stock Option Plan and Conditional Grant of Options

TORONTO, ONTARIO: TORONTO, ONTARIO -- (Marketwire) -- 08/16/11 -- RXT 110 INC. (CNSX: RXT) (the "Company") announced today that the board of directors has adopted a "rolling" employee stock option ...

AVI BioPharma Initiates Dosing in Phase 2 Study of Eteplirsen in Duchenne Muscular Dystrophy Patients

BOTHELL, WA: BOTHELL, WA -- (Marketwire) -- 08/15/11 -- AVI BioPharma, Inc. (NASDAQ: AVII), a developer of RNA-based therapeutics, today announced that it has initiated dosing in a Phase 2 study of eteplirsen, t ...

Cadus Reports Second Quarter 2011 Results

NEW YORK, NY: NEW YORK, NY -- (Marketwire) -- 08/15/11 -- (OTCBB: KDUS) announced today financial results for the second quarter ended June 30, 2011.Revenues were $0 for the second quarter of 2011 and for the same ...

NuPathe to Report Second Quarter 2011 Results and Hold Conference Call on Monday, August 15, 2011

CONSHOHOCKEN, PA: CONSHOHOCKEN, PA -- (Marketwire) -- 08/10/11 -- NuPathe Inc. (NASDAQ: PATH), a specialty pharmaceutical company focused on the development and commercialization of branded therapeutics for diseases o ...

SciClone Reports Financial Results for the Second Quarter of 2011

FOSTER CITY, CA: Year End Cash and Investments Guidance Updated ...

Sirona Biochem Appoints Dr. Bertrand Plouvier to Vice President, Product Development

VANCOUVER, BRITISH COLUMBIA: VANCOUVER, BRITISH COLUMBIA -- (Marketwire) -- 08/09/11 -- Sirona Biochem Corp. (TSX VENTURE: SBM) (the "Company"), a biotechnology company specializing in carbohydrate chemistry technolog ...

Hope Pharmaceuticals Releases a New FDA-Approved Antidote for Cyanide Poisoning

SCOTTSDALE, AZ: SCOTTSDALE, AZ -- (Marketwire) -- 08/08/11 -- Hope Pharmaceuticals today announced the launch of Nithiodote© (co-packaged Sodium Nitrite Injection, USP and Sodium Thiosulfate Injection, USP), a new ...

BioTech Insight Demonstrates Change Ahead - Research Report on Dendreon Corporation and OncoGenex Pharmaceuticals Inc.

MACAU: MACAU -- (Marketwire) -- 08/08/11 -- Today, announced its research report highlighting Dendreon Corporation (NASDAQ: DNDN) and OncoGenex Pharmaceuticals Inc. (NASDAQ: OGXI). Full content and resear ...

Leading Biotechnology Investor Lawrence Gozlan Joins Prana's Board of Directors

MELBOURNE, AUSTRALIA: MELBOURNE, AUSTRALIA -- (Marketwire) -- 08/08/11 -- (NASDAQ: PRAN) (ASX: PBT), today announced that Lawrence Gozlan, a leading biotechnology investor and advisor, has joined the Company's Board ...

MindUp BioResearch (HIRU) Research Team Published Their New Results on the Topic of Overcoming Multiple-Drug Resistance in Lung Cancer Therapy

BELGRADE, SERBIA: BELGRADE, SERBIA -- (Marketwire) -- 08/04/11 -- Hiru Corporation (PINK SHEETS: HIRU) (), is pleased to announce that researchers from its MindUp BioResearch (), European subsidiary have published th ...

Pivotal Therapeutics Inc. Extends Warrant Call

TORONTO, ONTARIO: TORONTO, ONTARIO -- (Marketwire) -- 08/04/11 -- Pivotal Therapeutics Inc. (CNSX: PVO), the developer of a proprietary prescription-grade Omega-3 product, formulated with a unique Eicosapentaenoic (E ...

DelMar Pharmaceuticals Receives Funding From the Canadian Federal Government

VANCOUVER, BRITISH COLUMBIA: VANCOUVER, BRITISH COLUMBIA -- (Marketwire) -- 08/04/11 -- DelMar Pharma today announced it has been awarded a non-refundable financial contribution from the National Research Council of Canada Indu ...

54% of Drug Companies Pursue In-Licensing Deals to Accelerate Development Timelines

RESEARCH TRIANGLE PARK, NC: RESEARCH TRIANGLE PARK, NC -- (Marketwire) -- 08/03/11 -- New data show that 54% of drug companies sign in-licensing deals to accelerate development timelines, according to Cutting Edge Information. ...

NuPathe Announces Common Stock Purchase Agreement for up to $30 Million

CONSHOHOCKEN, PA: Aspire Capital Makes Initial Investment of $500,000 at $7.07 per Share ...


Seite 65 von 66:  « ..  62  63  64 65 66 





 

Werbung



Facebook

Sponsoren

foodir.org The food directory für Deutschland
Informationen für Feinsnacker finden Sie hier.

Firmenverzeichniss

Firmen die firmenpresse für ihre Pressearbeit erfolgreich nutzen
1 2 3 4 5 6 7 8 9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z